BeEAM

DRUG3 trials

Sponsors

Centre Leon Berard, Insel Gruppe AG, University Hospital Bern, Northside Hospital, Inc.

Conditions

Follicular LymphomaLymphoma, FollicularLymphoma, Large B-Cell, DiffuseLymphoma, Mantle-CellMultiple Myeloma

Phase 2

BENdamustine at Elevated Dose for Relapsed Follicular Lymphoma in Intensification Therapy and Transplantation (BENEFIT)

TerminatedNCT02008006

Centre Leon BerardFollicular Lymphoma

Start: 2014-07-09End: 2018-07-12Updated: 2019-01-08

A Trial Comparing the Two High-dose Chemotherapies BeEAM and BEAM Given Before Autologous Stem Cell Transplantation (ASCT) in Lymphoma Patients (BEB-trial)

CompletedNCT02278796

Insel Gruppe AG, University Hospital BernLymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

Start: 2015-04-30End: 2020-11-30Updated: 2025-08-01

High Dose Chemotherapy Using BeEAM for Autologous Transplant in Multiple Myeloma

CompletedNCT02416206

Northside Hospital, Inc.Multiple Myeloma

Start: 2015-04-27End: 2021-04-21Updated: 2023-05-18

Related Papers

BendaEAM versus BEAM as conditioning regimen for ASCT in patients with relapsed lymphoma (BEB): a multicentre, randomised, phase 2 trial.

2023-11-192 citations